Implantable cardioverter defibrillators (ICDs) may be burdensome in end-stage heart failure. At the end of life, as many as one-fifth to one-third of patients experience an ICD shock. Critical care nurses should be aware of the potential burden of these shocks at the end of life as well as the ethics and organizational policies surrounding ICD deactivation. This literature review examines the issues surrounding ICD therapy at the end of life. Based on this author's findings, recommendations for discussing and implementing ICD deactivation are offered. Health care organizations should have clear policies addressing ICD deactivation to provide for seamless integration of palliative care services throughout the course of heart failure. These policies should empower nurses to activate resources in a timely manner and should clearly outline processes for ICD deactivation. (Critical Care Nurse. 2016;36[6]:24-32) 
Patients have the right to be informed of all options that might decrease pain and suffering at the end of life, including the option to deactivate ICD therapy. Critical care nurses often provide care for patients with heart failure at the end of life and play an important role in assessing patients' goals and preferences. Deactivation of an ICD is ethically acceptable and should be discussed with all patients when goals and preferences are likely to change. This literature review explores the issues surrounding ICD therapy at the end of life; based on this author's findings, recommendations for discussing and implementing device deactivation are provided.
ICD Therapy in End-Stage Heart Failure
An ICD reduces the risk of death from potentially lethal arrhythmias. In patients with heart failure, ICD implantation is often recommended for individuals with a reduced ejection fraction and a life expectancy greater than 1 year. 7 Unfortunately, providing an accurate prognosis in heart failure is difficult. Prognostication tools predict life expectancy in populations of patients, but cannot accurately predict how long an individual patient will live. 3 Heart failure has a changeable course, characterized by acute exacerbations followed by periods of relative stability. 1, 3, 6, [8] [9] [10] [11] [12] [13] It has been estimated that between 300 000 to 600 000 individuals in the United States have end-stage refractory heart failure. 6 The first ICDs became available in the 1980s, 14 and the prevalence of these devices continues to increase, 15 with most implanted in patients more than 65 years of age. 16 These devices may prolong life in some stages of heart failure, but given the increased prevalence of these devices at the end of life, it is crucial that health care professionals discuss device management when the goals of care change. Patients may not desire prolongation of life as heart failure advances and are not always aware of their progression into end-stage disease. The difficulty in prognostication and the changeable course of heart failure contribute to uncertainty about how close the patient is to death for both health care professionals and patients. 11 This uncertainty may delay end-of-life discussions and place patients at risk for increased pain and anxiety in the final hours of life because of ICD shocks.
Published reports suggest that 21% to 27% of patients receive a shock in the last 30 days of their life 14, 17 and that these shocks were distressing when witnessed by the patient's family. 17 In a Swedish study 18 of 130 ICD devices explanted postmortem, 31% of patients with active ICDs experienced a shock in the last 24 hours of life. Approximately half of the patients with a do-not-resuscitate (DNR) order still had active shock therapy at 1 hour before death, and 24% of these patients received shocks in the last hour of life. 18 In cases where the device was discharged, 55% of patients received at least 3 shocks, and 32% received more than 10 shocks.
18 Two-thirds of these shocks were not documented in the medical records and may not have been noticed by family or nursing staff; however, 19% did have a notation of pain or stress accompanying the shocks. 18 These statistics are in stark contrast to the estimated 14% of patients who receive a shock in the first year after implantation. 19 Patients are more likely to receive shocks at the end of life if their ICD has fired previously, but predicting which patients will receive a shock at the end of life is impossible.
2

ICD Deactivation
Patients' Preferences Regarding ICD Deactivation
Patients' knowledge and preferences about ICD deactivation are variable. Awareness of the option to deactivate the ICD has been estimated at 38% to 73%, 5, 20, 21 with some smaller studies noting that none of the participants knew this option existed. 17 Discussions about deactivation have been reported to occur with less than a third of patients who died with an ICD in place. 17 Patients' support for ICD deactivation were as low as 28% in one US study 22 and as high as 79% in the Netherlands. 20 In the US study, 26% of patients considered deactivation a form of physician-assisted suicide. 22 Culture and knowledge about ICD function may explain these disparate findings. Evidence indicates that some patients and health care professionals think that discussion of end-of-life issues is not acceptable in our culture. 23, 24 Withdrawal of life-prolonging devices at the end of life is frequently controversial, and although ICD deactivation is generally accepted, not every patient or health care professional is comfortable with it. In cases where the health care professional is not comfortable with deactivation, it is important that patients be referred to another professional who can assist them.
Ethical Considerations
The ethics of medical decision-making in the United States rest on the principles of autonomy, beneficience, nonmaleficience, and justice. Competent patients have the right to accept or refuse medical treatments. In addition, the Patient Self-Determination Act of 1991 provides the legal basis for this right. It is the obligation of health care professionals to ensure that patients understand the risks and benefits of all recommended therapies. Health care professionals have an ethical obligation to do no harm (nonmaleficience) and to act in patients' best interests (beneficience). Justice requires us to support all patients in these rights. These ethical principles are often operationalized as informed consent. Nurses, although not solely responsible for informed consent, should ensure that patients have adequate information on which to base their decisions.
As the burden of ICD therapy may outweigh benefits when patients' goals and preferences change, patients have the right to request deactivation of these devices. 2, 3, 5, 6, 12, 15, 16, [25] [26] [27] [28] [29] This right is well accepted and supported by the most recent guidelines on heart failure from the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA). 7 Although most published reports [2] [3] [4] [5] 20, 21, 29 support discussion of deactivation before implantation, in one study, 5 only 3% of patients recalled that this discussion actually occurred.
Health care organizations should have policies that ensure device deactivation is systematically addressed. 15 Although some patients may not choose deactivation, most want to be informed about the option of deactivation. 5, 20, 22 All patients with an ICD should understand the purpose of the device, as well as the risks, benefits, and options for device management as health declines. The literature suggests that patients may not have the information needed to make informed decisions and may not understand how the device works or the possible burden of active devices at the end of life. 30, 31 There may also be a knowledge deficit when it comes to understanding the nature of their condition. As a chronic condition with a progressive course, it is important that patients are able to periodically reevaluate whether to continue with ICD therapy. 31 Patients with heart failure tend to overestimate their life expectancy 21, 32 and often do not consider heart failure to be a life-limiting disease. 11, 30, 33 It is important that we develop guidelines for practice that ensure that patients are able to make informed decisions about device deactivation. A shared decisionmaking approach is suggested by the most recent guidelines from the American College of Cardiology Foundation and American Heart Association. 7 True informed consent and shared decision-making are difficult to achieve because it takes time to explain all the information that patients need to know in a way that they can understand. Patients may need more than one explanation or discussion to understand this information. Despite these difficulties, true informed consent should remain the goal. Policies and procedures in acute care settings can help us achieve this goal through a teambased systematic approach.
Recommendations
Key themes were identified on the basis of this author's review of the literature. Shocks from an ICD may be burdensome at the end of life and occur often when devices remain active. Discussions regarding deactivation did not take place consistently or early enough in the course of heart failure despite support for these discussions among health care professionals and patients. Guidelines and policies can be developed to improve care and uphold key ethical considerations for this population. Included are recommendations for (1) discussion before implantation, (2) triggers for discussion of ICD deactivation, (3) screening for devices upon admission, (4) interprofessional team discussions, and (5) incorporating palliative care into critical care settings. Additionally, recommendations are made for procedural processes when deactivation is requested.
Guidelines and Policy Development
Discussion Before Implantation. Health care organizations should develop policies to help health care professionals discuss deactivation at all points of care delivery, from insertion of the ICD to outpatient Nurses should ensure that patients have adequate information on which to base their decisions.
and acute management. Organizations where these devices are implanted or maintained should develop programs to better educate patients at the time of insertion. These educational programs should assist patients and their families in understanding the device functions and discuss situations in which patients may choose to have the device deactivated, as well as the ease of deactivation. Individualized nurse-led educational programs beginning before implantation with follow-up sessions improved patients' knowledge in a Turkish study. 34 Nurse educators can assist electrophysiologists by providing this in-depth teaching. Implantation should trigger a discussion about end-of-life preferences and the usual course of heart failure. 2, 21 This early discussion may make future discussions easier. Discussing end-oflife care early may normalize the topic and help patients and their families understand the life-limiting nature of heart failure. 1 Key teaching points about ICD deactivation are listed in Table 1 . Patients and their families should know that the defi brillation function can be turned off without deactivating pacing or cardiac resynchronization therapy. 2 Any misconception that deactivation is similar to euthanasia should be corrected. Evidence shows that patients believe that deactivation should be discussed at the time of implantation. 4, 5, 20 Patients should also understand that these devices may need periodic replacement. 2 The need for ICD replacement should be an additional trigger to assess patients' preferences, and replacement should not be automatic. 2, 3, 16 Triggers for Discussion of Deactivation. Hospital policy should ensure that when an order for DNR code status or "comfort measures only" is written, the provider should document that ICD deactivation was offered to the patient and/or surrogates. According to a survey of 558 physicians, the majority thought that deactivation discussions should accompany a DNR order. 4 Patient support is strong for advance directives that specifi cally address ICD deactivation at the end of life. 22 Writing a DNR order should trigger the provider to assess whether an ICD is present and whether the patient or surrogate would like the device deactivated. When discussions regarding deactivation are incorporated into end-of-life conferences, patients receive fewer shocks in the time preceding death. 14 Despite support for offering deactivation for patients with DNR orders, 1 study 18 demonstrated that only 50% of patients have had the ICD deactivated 1 hour before death. Deactivation should also be discussed whenever clinical signs of a poor prognosis are present.
Screening. Upon admission, patients should be screened for the presence of an ICD. Patients and their families may not remember the type of device or may forget to mention the device. 15 Devices can usually be detected by inspecting and palpating the anterior chest wall and are identifi able via chest radiography. The chest radiograph will indicate what programmer is required to interrogate the device. 36 When specifi c information about the device settings is not available through the patient or medical records, the device should be interrogated and the fi ndings documented carefully in the medical record. This information should be easily accessible and in a place where all caregivers will see it. Without screening, health care professionals may not be able to address deactivation when indicated. There may come a time when ICD therapy causes more burdens than benefi ts; for example, at the end of life or in the case of a terminal disease.
ICD therapy can be painful and distressing to experience and witness at the end of life.
Deactivation will not cause death, but the ICD will not automatically treat potentially life-threatening arrhythmias in the future.
Pacemaker and resynchronization functions can be retained when deactivating defi brillation.
ICDs may need periodic replacement, and patients can choose not to replace ICDs.
The patient is unlikely to notice or feel anything different after deactivation. Deactivation is painless.
Defi brillation can be deactivated urgently by using a strong magnet placed over the device.
a Based on information from Matlock and Stevenson, 2 Jezewski and Meeker, 24 and Swetz and Mansel. 35 Nurses should be empowered to initiate discussions about deactivation with the interprofessional team.
Interprofessional Teams. Health care organizations should provide for regular interprofessional discussions about patient goals in which bedside nurses have a meaningful role. Nurses spend the largest portion of time with patients and can provide valuable input when the team's goals of care do not align with the patient's goals and preferences. Nurses should be empowered to initiate discussions about deactivation with the interprofessional team at key trigger points (Table 2) . Nurses are responsible for acknowledging and advocating for the needs of patients and patients' families. 33 In critical care environments, it is easy to focus on physiological processes and curative paradigms. Bedside nurses should assert their knowledge of the whole individual and assist in steering interdisciplinary goals to meet the needs of patients and patients' families.
Palliative Care in Critical Care. One common misconception is that palliative care is mutually exclusive with life-prolonging or curative treatment and is reserved for the last days of life. 10, 35, 37, 38 On the contrary, palliative care should begin with the diagnosis of heart failure and continue throughout the course of the disease. 10 Palliative care is treatment with a focus on the prevention and relief of suffering. 35 In the ICU, palliative care may not only help manage symptoms, but can assist the team in alignment of goals and provide support for patients and their families. 35 Acute care organizations should provide seamless integration and/or referral to palliative care services. 35 Protocols should be developed to allow nurses to independently activate these services when indicated.
Procedures
Successful implementation of policies is enhanced when there are procedural outlines to follow. Health care organizations should have clear procedures indicating how ICDs are deactivated when requested by patients or surrogates. These procedures should include pathways for nonurgent and urgent deactivation (Table 3) . Nonurgent pathways may outline which providers should be consulted when ordering deactivation, how to request deactivation by trained staff, and a timeline for how long this process should take. Urgent pathways should allow bedside nurses to deactivate the ICD with a magnet under specifi c circumstances. Consider a situation in which a patient with a DNR order is requesting urgent deactivation following a shock. This pathway would be needed only if a patient or surrogate had decided against deactivation but, after a shock, changes his or her mind. This 
Rationale
Informed consent should provide education about function and the possibility of deactivation at a future time.
Patients are more likely to be aware of their mortality and the possible burdens of defi brillation.
Frequent hospitalizations may indicate the steady decline in health before death.
ICDs provide life-sustaining treatment and may not be consistent with patients' preferences to avoid resuscitation and are antithetical to comfort measures.
Hospice referrals are made when life expectancy is 6 months or less, ICDs are indicated only in patients with a life expectancy of at least 1 year and may prolong suffering.
Functional decline may change patients' goals and preferences as they become more dependent on caregivers to meet basic needs.
These stages of heart failure are considered end stage, and the value of ICDs in advanced stages is not proven.
These are clinical signs of poor prognosis in heart failure.
a Based on information from Goodlin et al, 1 Matlock and Stevenson, 2 Allen et al, 3 Hupcey et al, 10 Wingate and Wiegand, 12 Wotton et al, 13 Kirk, 15 and Jezewski and Meeker.
suggested protocol would help alleviate suffering for patients at the time of death and would provide nurses with the ability to act quickly. Empowering nurses with such a protocol might also reduce the risk of moral distress.
Discussion
Support for deactivation of ICDs at the end of life is apparent, and this article has provided some guidelines to assist critical care units and nurses in policy development. Although it is ethically acceptable to deactivate ICDs when a patient requests, deactivation should not be automatic for every patient at the end of life. 15 Patients have the right to continue ICD therapy even when requesting DNR or comfort status. Many patients develop complex psychological relationships with their device and see it as a "trusted friend" or "insurance policy." 30 Results of a survey of 105 patients with heart failure indicate that many were reluctant to deactivate their device even when asked to consider a hypothetical terminal disease or daily shocks. 21 Although some patients may be reluctant to deactivate their device, they also have the right to change their mind and should not be forced to endure suffering in their fi nal hours.
Nurses can support decision-making by communicating with patients about their goals and preferences (Table 4) . In order for these conversations to be meaningful, nurses need to allot an appropriate amount of time to explore and ensure understanding of a patient's perspective. Providing opportunities for patients and their families to express feelings may reveal values that are incongruent with the care provided. To advocate for patients, nurses must understand the needs of patients and their families. 33 Asking questions to determine what a patient understands about his or her condition can reveal knowledge defi cits. Whenever a patient's values, goals, preferences, or understanding is incongruent with the clinical picture, nurses should discuss these concerns with the 
Nonurgent deactivation pathway
Patient is not experiencing distress and is not likely to receive a shock in the near future
Urgent deactivation pathway
Patient has recently or is currently receiving shocks and is in distress Deactivation is requested by patient or legal surrogate and witnessed by 2 nurses. Primary nurse places magnet over the device to urgently deactivate it and relieve the patient's distress.
Attending provider is notifi ed and initiates the nonurgent pathway to permanently deactivate the device.
Facility without electrophysiology services
Deactivation is requested by patient or appropriate surrogate Attending provider notifi ed Attending provider discusses deactivation options with the patient and writes the order for deactivation of specifi c features • Seeks assistance from manufacturer to obtain the programmer and technical expertise • Contacts the patient's primary cardiologist or electrophysiologist to discuss patient's wishes interprofessional team. Whenever possible, a health care professional who has an existing relationship with the patient should be involved because patients may prefer that this person be the one to address end-of-life issues.
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When deactivation is chosen, nurses should be prepared for the possibility that the patient might have a different course of dying, and death could occur abruptly with a sudden loss of consciousness. 40 Patients and their families may expect an acute change immediately after deactivation and should be taught that the patient is unlikely to look or feel any different afterwards.
2 Regardless of whether a patient chooses to deactivate an ICD at the end of life or to continue with ICD therapy, the patient's informed decision should be honored and respected.
Conclusion
Deactivation of an ICD should be discussed with all patients periodically, especially at the end of life, when the device can lead to suffering without benefit. Health care organizations should have clear policies and procedures for nurses to follow in advocating for their patients. These policies should include (1) discussing deactivation and providing education before implantation, (2) screening for and documentation of ICD presence, (3) an interprofessional team-based approach to goal setting, (4) seamless integration of palliative care services, and (5) ensuring that deactivation is addressed with DNR orders and with signs of worsening prognosis. Urgent and nonurgent pathways for deactivation should be created. The implementation of these recommendations may reduce painful shocks at the end of life and improve care for patients who have an ICD. &&1
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